Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen F. Brady is active.

Publication


Featured researches published by Stephen F. Brady.


Biochemical and Biophysical Research Communications | 1988

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins.

Paul L. Darke; Ruth F. Nutt; Stephen F. Brady; Victor M. Garsky; Terrence M. Ciccarone; Chih-Tai Leu; Patricia K. Lumma; Roger M. Freidinger; Daniel F. Veber; Irving S. Sigal

The mature proteins of retroviruses originate as a result of proteolytic cleavages of polyprotein precursors. Retroviruses encode proteases responsible for several of these processing events, making them potential antiviral drug targets. A 99-amino acid HIV-1 protease, produced by chemical synthesis or by expression in bacteria, is shown here to hydrolyze peptides corresponding to all of the known cleavage sites in the HIV-1 gag and pol polyproteins. It does not hydrolyze peptides corresponding to an env cleavage site or a distantly related retroviral gag cleavage site.


Life Sciences | 1984

A super active cyclic hexapeptide analog of somatostatin

Daniel F. Veber; Richard Saperstein; Ruth F. Nutt; Roger M. Freidinger; Stephen F. Brady; Paul E. Curley; Debra S. Perlow; William J. Paleveda; C. Dylion Colton; Anthony G. Zacchei; Dominick J. Tocco; Dale Richard Hoff; Richard L. Vandlen; J. E. Gerich; L. D. Hall; Lawrence J. Mandarino; Eugene H. Cordes; Paul S. Anderson; Ralph F. Hirschmann

The cyclic hexapeptide, cyclo (Pro-Phe-D-Trp-Lys-Thr-Phe), I, has been shown to have the biological properties of somatostatin. We now report structure-activity studies which optimize the potency of this cyclic hexapeptide series with the synthesis of cyclo (N-Me-Ala-Tyr-D-Trp-Lys-Val-Phe), II, which is 50-100 times more potent than somatostatin for the inhibition of insulin, glucagon and growth hormone release. The hydroxyl group of tyrosine is seen to lend a 10-fold enhancement to the potency. Potency also is found to be correlated with hydrophobicity. II is found to improve the control of postprandial hyperglycemia in diabetic animals when given in combination with insulin. The analog is found to be quite stable in the blood and in the gastrointestinal tract, but the bioavailability after oral administration is only 1-3%. The biological properties and long duration of II should allow clinical evaluation of the inhibition of glucagon release as an adjunct to insulin in the treatment of patients with diabetes.


Psychopharmacology series | 1987

Synthesis of New Peptides Based on Models of Receptor-Bound Conformation

Roger M. Freidinger; Stephen F. Brady; William J. Paleveda; Debra S. Perlow; Christiane D. Colton; Willie L. Whitter; Richard Saperstein; E. J. Brady; Margaret A. Cascieri; Daniel F. Veber

About three dozen small peptides (mostly 2–40 residues) have been identified in the nervous system (Iversen 1983,1984; Krieger 1983). The neuropeptides mediate a wide range of endocrine, motor, and behavioral responses (Snyder 1980; Krieger 1983). These substances control such diverse functions as growth, reproduction, digestion, metabolism, and the dynamics of the cardiovascular system. Immunostaining techniques have been used to visualize and map the distribution of peptides, in particular neuronal pathways. Many of these substances have also been shown to occur in peripheral regions, such as the gastrointestinal tract. The role of many of these agents is largely unknown, but their potential utility in therapy is great.


International Journal of Peptide and Protein Research | 2009

NMR and molecular modeling characterization of RGD containing peptides

M.J. Bogusky; A.M. Naylor; S.M. Pitzenberger; Ruth F. Nutt; Stephen F. Brady; C.D. Colton; J.T. Sisko; P.S. Anderson; Daniel F. Veber


Archive | 1984

Cardiac atrial peptides

Stephen F. Brady; Mary A. Napier; Ruth F. Nutt; Richard L. Vandlen


Archive | 1990

Peptides having ANF activity

Stephen F. Brady; Ruth F. Nutt


International Journal of Peptide and Protein Research | 2009

Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanine

Stephen F. Brady; David W. Cochran; Ruth F. Nutt; Frederick W. Holly; Carl D. Bennett; William J. Paleveda; Paul E. Curley; Byron H. Arison; Richard Saperstein; Daniel F. Veber


Archive | 2002

Beta-secretase substrates and uses thereof

James E. Bruce; Xiaoting Tang; Victor M. Garsky; Stephen F. Brady; Yueming Li; Elizabeth Chen-Dodson; Mohinder K. Sardana; Jules A. Shafer


Archive | 1991

Peptides having atrial natriuretic factor activity

Ruth F. Nutt; Stephen F. Brady; Daniel F. Veber; Theresa M. Williams


Biochemical Society Transactions | 1985

Renin inhibitors containing 2-substituted statine

Mark G. Bock; Joshua S. Boger; Stephen F. Brady; Daniel F. Veber

Collaboration


Dive into the Stephen F. Brady's collaboration.

Researchain Logo
Decentralizing Knowledge